Pursuant to Regulation 39(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Sun Pharmaceutical Industries has informed that it enclosed the details of loss of share certificate reported by shareholder of the Company. The Company will duly issue letter of confirmation in lieu of original share certificate.
The above information is a part of company’s filings submitted to BSE.